-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Avidity Biosciences, Inc. quarterly/annual Depreciation history and growth rate from Q1 2020 to Q2 2024.
- Avidity Biosciences, Inc. Depreciation for the quarter ending June 30, 2024 was $700K, a 40% increase year-over-year.
- Avidity Biosciences, Inc. Depreciation for the twelve months ending June 30, 2024 was $2.55M, a 53.3% increase year-over-year.
- Avidity Biosciences, Inc. annual Depreciation for 2023 was $2.1M, a 51.5% increase from 2022.
- Avidity Biosciences, Inc. annual Depreciation for 2022 was $1.39M, a 117% increase from 2021.
- Avidity Biosciences, Inc. annual Depreciation for 2021 was $639K, a 71.3% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)